TRIAL DESIGN
Your trial CORE-powered
Site identification
PATIENT RECRUITMENT
EXECUTION
BACK
TRIAL DESIGN
TRIAL DESIGN
Trial Design
Access real-world analytics to determine feasibility in your trial design
Our CORE-powered approach uses real-world and commercial insights to identify design inconsistencies, patient burden, and patient eligibility potential to better inform and validate protocols for operational risks.
THE PROOF
About 70% of protocols are positively impacted by IQVIA's protocol assessments, resulting in an estimated 1-3 months savings
70
%
protocols positively
impacted
1-3 months savings
Site IDENTIFICATION
Site Identification
Real-world patient density data and predictive site models enable faster site and investigator identification
Transform site selection by embedding analytics within operations and developing a proprietary process to identify high-performance sites for a trial.
Bypass lower performing sites for a 46% faster site identification
THE PROOF
46
%
faster site
identification
Note: data as of January 2020; proof points are dynamically tracked and will vary as trials progress through
delivery; sample sizes vary as trials in the portfolio are at different stages of start-up and enrollment
PATIENT RECRUITMENT
Patient Recruitment
Pinpoint the right patient populations, where they are
and boost patient engagement
Use real-world data to more accurately predict recruitment at prioritized sites, and empower the CRA to drive recruitment plans and screening activity based upon evidence.
Increase patient recruitment over historical comparators of non-prioritized sites
THE PROOF
Note: data as of January 2020; proof points are dynamically tracked and will vary as trials progress through
delivery; sample sizes vary as trials in the portfolio are at different stages of start-up and enrollment
50
%
increase in
enrollment
EXECUTION
Execution
Increase data quality, efficiency and patient safety
through end-to-end monitoring
Use predictive analytics to identify sites that are highly likely to show a particular risk behavior, as well as patients who are at risk for non-compliance. We are leveraging Artificial Intelligence (AI) and Machine Learning to improve the safety of patients participating in the trial by proactively identifying patients at risk and increase monitoring to safeguard patients.
4X lower error rate in critical data
THE PROOF
4X
error rate
PATIENT RECRUITMENT
EXECUTION
Through our CORE-powered approach to clinical development, IQVIA will help you rethink old challenges into new opportunities and surround your trial with a proven suite of capabilities to help you reach milestones faster, deliver programs within budget, and bring differentiated therapies to patients sooner.
Experience the proof, not promises.
LOWER
Site identification
Your trial CORE-powered
Your trial CORE-powered
Your trial CORE-powered
Your trial CORE-powered
Your trial CORE-powered
Your trial CORE-powered